Trademark: 77190373
Word
TIME IS LIFE
Status
Dead
Status Code
606
Status Date
Monday, May 2, 2011
Serial Number
77190373
Mark Type
4000
Filing Date
Friday, May 25, 2007
Published for Opposition
Tuesday, August 3, 2010
Abandoned Date
Monday, May 2, 2011

Trademark Owner History
Paion Deutschland GmbH - Owner At Publication

Classifications
1 Reagents for scientific or medical research use; diagnostic preparations or reagents for scientific or research use, biochemical reagents for scientific or medical research use; biochemical diagnostic preparations or reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use
5 Pharmaceutical preparations, namely, pharmaceutical preparations derived from living organism proteins and peptides for treatment and diagnosis of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; pharmaceutical anti-inflammatory preparations; pharmaceutical nutriceutical preparations for the treatment of strokes, neuron damage, thrombotic diseases, tumors, cancer, heart disease including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; blood clotting test kits comprised of medical diagnostic reagents
10 Laboratory devices for medical and pharmaceutical investigations, namely, portable medical devices for conducting medical diagnostic tests and blood specimen analysis of the human blood clotting system; medical devices, namely, coated catheters, medical stents, surgical implants comprising artificial materials; membranes intended for medical use, namely, filters for dialysis and hemofiltration
35 Computerized database management, namely, processing data for third parties in the field of drug development
41 Educational services, namely, providing seminars and workshops in the field of biotechnology, pharmacology, biochemistry, molecular biology, medical procedures, product research and development of medical devices and pharmaceutical preparations, research procedures, protein design diagnostics, molecular diagnostics, proteogenomic profiling, and gendiagnostics
42 Database development for others; computer programming for others; performing chemical analyses for others; technical consultation in the field of biotechnology; services of a biotechnological laboratory, namely, conducting laboratory research for others in the field of drug research and development; pharmaceutical research consulting, namely, performing pre-clinical studies; performing quality control for others; preparation of expert opinions in the field of chemical engineering, biology, molecular biology, pharmacology, chemistry, bio-technology, bio-chemistry; product research and development of medical devices and pharmaceutical preparations, and molecular diagnostic services of a bio-chemist, namely, product research and development services for others in the area of gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development and identifying, designing and analyzing therapeutic proteins; diagnostic research services in the field of molecular science, comparative genome analysis, DNA-arrays including DNA-microarrays, creation of nucleic acid libraries, screening of nucleic acid libraries; performance of pre-clinical research namely, conducting and managing pre-clinical trials and studies of pharmaceutical, bio-technology and health care products; biochemical and biotechnological research and development for others, namely, bio-technological research and development regarding medical disease diagnosis and pharmacology, namely, prenatal diagnostic and identification of hereditary factors leading to diseases, identification of genes involved in the formation of cancer, identification of target molecules for cancer treatment; scientific research on and development of medical diagnostic equipment and pharmaceutical preparations and products for the treatment of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; scientific and technical consulting for others in the field of medical science and drug research, namely, identifying, designing, and developing drugs, specifically, therapeutic proteins, gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development, identification and design; medical science research services for others, namely, prenatal diagnostics, molecular diagnostics, comparative genome analysis, DNA-arrays including DNA-microarrays, creating and screening of nucleic acid libraries, identifying hereditary factors leading to diseases, identifying genes involved in the formation of cancer, identification of target molecules for cancer treatment

Trademark Events
May 2, 2011
Abandonment Notice Mailed - No Use Statement Filed
May 2, 2011
Abandonment - No Use Statement Filed
Sep 28, 2010
Noa E-Mailed - Sou Required From Applicant
Aug 3, 2010
Official Gazette Publication Confirmation E-Mailed
Aug 3, 2010
Published For Opposition
Jun 29, 2010
Law Office Publication Review Completed
Jun 28, 2010
Approved For Pub - Principal Register
Jun 18, 2010
Teas/Email Correspondence Entered
Jun 18, 2010
Correspondence Received In Law Office
Jun 18, 2010
Assigned To Lie
Jun 8, 2010
Teas Response To Office Action Received
Dec 9, 2009
Notification Of Non-Final Action E-Mailed
Dec 9, 2009
Non-Final Action E-Mailed
Dec 9, 2009
Non-Final Action Written
Nov 19, 2009
Teas/Email Correspondence Entered
Nov 19, 2009
Correspondence Received In Law Office
Nov 19, 2009
Teas Response To Office Action Received
May 30, 2009
Notification Of Non-Final Action E-Mailed
May 30, 2009
Non-Final Action E-Mailed
May 30, 2009
Non-Final Action Written
May 27, 2009
Teas/Email Correspondence Entered
May 26, 2009
Correspondence Received In Law Office
May 26, 2009
Teas Response To Suspension Inquiry Received
Apr 9, 2009
Notification Of Inquiry As To Suspension E-Mailed
Apr 9, 2009
Inquiry To Suspension E-Mailed
Apr 9, 2009
Suspension Inquiry Written
Apr 6, 2009
Lie Checked Susp - To Atty For Action
Oct 6, 2008
Notification Of Letter Of Suspension E-Mailed
Oct 6, 2008
Letter Of Suspension E-Mailed
Oct 6, 2008
Suspension Letter Written
Sep 22, 2008
Lie Checked Susp - To Atty For Action
Mar 21, 2008
Report Completed Suspension Check Case Still Suspended
Mar 20, 2008
Assigned To Lie
Sep 13, 2007
Notification Of Letter Of Suspension E-Mailed
Sep 13, 2007
Letter Of Suspension E-Mailed
Sep 13, 2007
Suspension Letter Written
Sep 7, 2007
Notification Of Non-Final Action E-Mailed
Sep 7, 2007
Non-Final Action E-Mailed
Sep 7, 2007
Non-Final Action Written
Sep 6, 2007
Assigned To Examiner
Aug 16, 2007
Teas Voluntary Amendment Received
Jun 1, 2007
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24